Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jan;95(1):E28-E30.
doi: 10.1002/ajh.25682. Epub 2019 Nov 25.

Axicabtagene ciloleucel for CD19+ plasmablastic lymphoma

Affiliations
Free article
Case Reports

Axicabtagene ciloleucel for CD19+ plasmablastic lymphoma

Ruben Raychaudhuri et al. Am J Hematol. 2020 Jan.
Free article
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Bentley S. WHO classification of tumours: pathology and genetics. Tumours of haematopoietic and lymphoid tissues. Clin Lab Haematol. 2003;25(3):201-201. https://doi.org/10.1046/j.1365-2257.2003.00518.x.
    1. NCCN. NCCN Clinical Practice Guidelines in Oncology. B-Cell Lymphoma. 2018. https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf.
    1. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008;83:804-809. https://doi.org/10.1002/ajh.21250.
    1. Castillo JJ, Winer ES, Stachurski D, et al. HIV-negative plasmablastic lymphoma: not in the mouth. Clin Lymphoma Myeloma Leuk. 2011;11(2):185-189. https://doi.org/10.1016/J.CLML.2011.03.008.
    1. Castillo JJ, Guerrero-Garcia T, Baldini F, et al. Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. Br J Haematol. 2019;184(4):679-682. https://doi.org/10.1111/bjh.15156.

LinkOut - more resources